Company Monitoring Page for MedImmune

latest headlines for company on cafepharma

AstraZeneca unit loses patent rights
FT.com
Wed, 07/6/11 - 08:17 am
Tags:
AstraZeneca, patents, Roche, MedImmune, ranibizumab, Novartis
PDL Settles MedImmune Dispute
Yahoo/Zacks.com
Fri, 02/18/11 - 03:17 pm
Tags:
PDL Biopharma, MedImmune, AstraZeneca, RSV, Synagis, Abbott Laboratories
PDLI's Synagis Lawsuit Invalidated
Yahoo/Zacks.com
Tue, 01/11/11 - 02:36 pm
Tags:
Synagis, PDL Biopharma, MedImmune, lawsuits, Abbott Laboratories
MedImmune inks $342M collaboration on diabetes program
Fierce Biotech
Thu, 12/16/10 - 01:11 pm
Tags:
MedImmune, diabetes, Evotec
Pharma Mergers Scrutinized In Insider Trading Probe
Reuters
Fri, 12/3/10 - 08:24 am
Tags:
M&A, insider trading, MedImmune, AstraZeneca, Wyeth, Pfizer, Merck, Schering Plough
Biotech Ends October With Almost $1B in IPOs, $3B in M&A Activity, $3B in Possible Partnerships
Seeking Alpha
Sun, 10/31/10 - 11:35 am
Tags:
Teva Pharmaceuticals, Sanofi, Pfizer, Pacific Biosciences, Merck, Macrogenics, Hikma, GSK, BMP Sunstone, biotech, Baxter International, Amicus Therapeutics, Immune Design, MedImmune
Good News for Micromet
Yahoo/Zacks.com
Wed, 10/13/10 - 12:12 pm
Tags:
Micromet, MedImmune, AstraZeneca
MedImmune Bets Its Fate on “Biobetters”
PharmExec
Fri, 09/10/10 - 11:21 am
Tags:
MedImmune, AstraZeneca, biosimilars
Red Signal for AstraZeneca Drug
Yahoo/Zacks.com
Mon, 09/6/10 - 10:01 am
Tags:
AstraZeneca, MedImmune, RSV, motavizumab
Synagis' Special Status Under Health Care Reform
InVivo
Tue, 08/24/10 - 07:23 am
Tags:
RSV, MedImmune, Synagis, AstraZeneca
Cornerstone buys back technology from MedImmune
Yahoo/AP
Tue, 07/6/10 - 10:46 am
Tags:
Cornerstone Therapeutics, MedImmune
FDA Resets Motavizumab Decision to Aug. 27
TopWireNews
Sat, 06/26/10 - 10:50 am
Tags:
motavizumab, RSV, MedImmune, AstraZeneca
FDA Committee Votes to Reject AstraZeneca RSV Drug: Biotech's Latest Mishaps
Seeking Alpha
Sun, 06/6/10 - 11:03 am
Tags:
RSV, AstraZeneca, MedImmune, motavizumab, Axanum
FDA panel rejects AZ's new RSV drug in key setback
Fierce Biotech
Thu, 06/3/10 - 10:07 am
Tags:
RSV, motavizumab, MedImmune, FDA, AstraZeneca
FDA Panel Recommends Single Flu Vaccine
WSJ Online
Mon, 02/22/10 - 03:33 pm
Tags:
FDA, vaccines, H1N1, Flu, GSK, Novartis, Sanofi, CSL, MedImmune
AstraZeneca still waiting for the upside to MedImmune acquisition
Bizjournals.com
Fri, 02/5/10 - 10:30 am
Tags:
MedImmune, AstraZeneca, M&A
Pivotal Trial Results for Motavizumab Published in Current Issue of 'Pediatrics'
Yahoo/PR NewsWire
Sat, 01/30/10 - 11:10 am
Tags:
MedImmune, motavizumab, RSV
MedImmune responds to FDA on pediatric drug
Bizjournals.com
Mon, 12/28/09 - 04:41 am
Tags:
FDA, MedImmune, Synagis, RSV
MedImmune licenses RSV antibodies in $338M deal
Fierce Biotech
Tue, 12/1/09 - 10:25 am
Tags:
RSV, antibodies, MedImmune, liscensing, Trellis Biosciences
Micromet takes back MedImmune's blinatumomab rights
Fierce Biotech
Fri, 11/6/09 - 10:46 am
Tags:
MedImmune, blinatumomab, Micromet

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.